<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1372">
 <bold>Conclusions:</bold> The prevalence of ESBL and CPB is increasing day by day in nearly every center of different countries and is responsible for large number of hospital-acquired and nosocomial infections, with very few, if any, therapeutic options. Necessary steps to prevent the spread and emergence of resistance should be taken.
</p>
